SCHEMBL381728

SCHEMBL381728

O=C(c1ccc(-c2cc(Cl)c(CC3CCN(C4CCNCC4)C3=O)c(Cl)c2)cc1)N1CCN(CC(F)(F)F)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 1/20 0.37
ABL1 P00519 3/20 0.37
BCR P11274 3/20 0.37
TPSAB1 Q15661 1/20 0.37
TPSD1 Q9BZJ3 1/20 0.37
TPSG1 Q9NRR2 1/20 0.37
KCNH2 Q12809 3/20 0.35
UTS2R Q9UKP6 3/20 0.34
EGLN1 Q9GZT9 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
LSS P48449 1/20 0.33
PDE5A O76074 1/20 0.33
PDE4A P27815 1/20 0.33
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
PDE7A Q13946 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL381727 1.00 NPY1R (0.37) NPY1RABL1BCRTPSAB1TPSD1
SCHEMBL209061 0.92 HSD11B1 (0.39) ABL1BCRL3MBTL1L3MBTL3LSS
SCHEMBL207707 0.91 ABL1 (0.35) NPY1RABL1BCRLSSMET
SCHEMBL207709 0.91 ABL1 (0.35) NPY1RABL1BCRLSSMET
SCHEMBL207708 0.91 ABL1 (0.35) NPY1RABL1BCRLSSMET
SCHEMBL209575 0.91 ABL1 (0.35) NPY1RABL1BCRLSSMET
SCHEMBL209599 0.90 HRH3 (0.37) ABL1BCRKCNH2MET
SCHEMBL209598 0.90 HRH3 (0.37) ABL1BCRKCNH2MET
SCHEMBL3124490 0.89 FASN (0.35) ABL1BCRLSSPDE5APDE4A
SCHEMBL3124484 0.89 FASN (0.35) ABL1BCRLSSPDE5APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049513-B1 PIPERIDINYL SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2012-01-25 EP disclosed
US-7829582-B2 Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2010-11-09 US disclosed
US-20090088430-A1 PIERIDINYL SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088430-A1 PIERIDINYL SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD3B1 NPY1R 287/4885ABL1 2479/4885BCR 1105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.